| |
| |
|
| Insider
Information: |
Do Hung |
| Relationship: |
Chief Science Officer |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
448,617 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,759,826 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
448,617 |
|
|
| Total
Value |
$4,759,826 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
Chief Science Officer |
2021-04-06 |
448,617 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
60 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2015-05-27 |
4 |
D |
$11.77 |
$59 |
D/D |
(5) |
745,953 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2015-09-15 |
4 |
AS |
$17.75 |
$443,668 |
D/D |
(25,000) |
720,953 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
633,453 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2016-08-04 |
4 |
AS |
$7.00 |
$175,000 |
D/D |
(25,000) |
608,453 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2016-09-06 |
4 |
AS |
$7.00 |
$175,000 |
D/D |
(25,000) |
583,453 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2016-10-03 |
4 |
AS |
$7.25 |
$181,250 |
D/D |
(25,000) |
558,453 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2016-11-01 |
4 |
AS |
$7.00 |
$175,000 |
D/D |
(25,000) |
533,453 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
50,813 |
584,266 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-01-13 |
4 |
AS |
$6.00 |
$150,000 |
D/D |
(25,000) |
559,266 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-02-07 |
4 |
AS |
$6.00 |
$150,000 |
D/D |
(25,000) |
534,266 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-05-15 |
4 |
AS |
$8.00 |
$239,312 |
D/D |
(29,914) |
504,352 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-05-19 |
4 |
AS |
$8.00 |
$239,312 |
D/D |
(29,914) |
474,438 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-06-15 |
4 |
D |
$8.79 |
$10,820 |
D/D |
(1,231) |
473,207 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-10-12 |
4 |
OE |
$14.25 |
$715,360 |
D/D |
50,194 |
523,401 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-10-12 |
4 |
AS |
$14.25 |
$715,360 |
D/D |
(50,194) |
473,207 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2018-01-03 |
4 |
D |
$15.67 |
$97,765 |
D/D |
(6,239) |
496,771 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2018-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
29,803 |
503,010 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2018-04-17 |
4 |
AS |
$15.00 |
$750,000 |
D/D |
(50,000) |
446,771 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2018-05-16 |
4 |
AS |
$15.00 |
$375,000 |
D/D |
(25,000) |
421,771 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2018-06-01 |
4 |
AS |
$16.72 |
$418,000 |
D/D |
(25,000) |
396,771 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
61,063 |
457,834 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2019-01-03 |
4 |
D |
$10.33 |
$98,352 |
D/D |
(9,521) |
448,313 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2019-01-15 |
4 |
AS |
$12.00 |
$199,200 |
D/D |
(16,600) |
439,913 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2019-01-15 |
4 |
OE |
$2.94 |
$32,430 |
D/D |
8,200 |
456,513 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2019-01-16 |
4 |
OE |
$2.94 |
$168,749 |
D/D |
35,024 |
474,937 |
0 |
- |
|
60 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
